Remote atrial fibrillation monitoring before consultation proves significant time and cost savings

Key benefits

Reduced costs

Increased efficiency

Time savings for patients and clinics

Reliable real-time data for clinical decision-making

Enhanced patient safety and satisfaction

Member empowerment

Key benefits

Reduced costs

Increased efficiency

Time savings for patients and clinics

Reliable real-time data for clinical decision-making

Enhanced patient safety and satisfaction

Member empowerment

How does it work?

Project outline:Through a collaboration between FibriCheck, MUMC+ and Biosense Webster, the TeleCheck-AF project enabled over 40 European clinics to use tele-consultations supported by app-based heart rate and heart rhythm monitoring for the follow up and management of patients with AF or suspected AF.

FibriCheck enables patients to measure their heart rate and rhythm prior to their consultation and provides them with educational information about AF, its complications and treatment via the app. The data from the FibriCheck measurements allows treating physicians and nurses to gain insights into the heart rate and rhythm of patients prior to their consultation, supporting their clinical decision making. FibriCheck as a remote monitoring tool pre-consultation greatly reduces the burden on healthcare systems, as research proved that the implementation of this digital pathway resulted in 71% fewer ECG examinations, 72% less need for Holter monitors, 75% shorter consultations times and 75% less travel time expenditure, thereby leading to significant time and cost savings. Patients indicated increased feelings of safety (85%) and satisfaction, and found FibriCheck easy to use (100%). Thanks to the success and the scalability of this digital pathway, app-based remote heart rhythm measurements and tele-consultations are now the standard for patients suffering from AF, with the project even paving the way for a FibriCheck reimbursement code by Dutch healthcare insurer VGZ.